Sign in

CIK 0001711279 · Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
821080209
Phone
(412) 586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
  1. 4 Gift Director gave 3,500 shares (gift)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Planned sale President, R&D sold 25,000 shares at an average $359.32 ($8,982,986)
  9. 4 Planned sale President and CEO sold 25,000 shares at an average $359.32 ($8,983,084)
  10. 4 Open-market sale Director sold 25,000 shares at an average $329.12 ($8,227,953)
  11. 4 Planned sale EVP, General Counsel sold 1,000 shares at $347.27 ($347,270)
  12. 4 Planned sale President, R&D sold 25,000 shares at an average $308.11 ($7,702,825)
  13. 4 Planned sale President and CEO sold 25,000 shares at an average $308.12 ($7,702,984)
  14. 4 Planned sale EVP, General Counsel sold 642 shares at $302.03 ($193,903)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Planned sale President, R&D sold 25,000 shares at an average $263.21 ($6,580,270)
  18. 4 Planned sale President and CEO sold 25,000 shares at an average $263.17 ($6,579,164)
  19. 4 Planned sale Chief Accounting Officer sold 750 shares at $267.60 ($200,700)
  20. 4 Shares withheld for taxes President, R&D gave up 30,584 shares (to pay taxes)

Page 1 of 10 · 186 filings